share_log
Reuters ·  Mar 28 12:33
Silexion Therapeutics Corp - to Conduct Additional Toxicology and Pharmacodynamic Studies in 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 244

Recommended

Write a comment